A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Recurrence Free Survival (RFS)
362 events
Yes
Craig Slingluff, M.D.
Principal Investigator
Martha Jefferson Hospital, University of Virginia
United States: Food and Drug Administration
103A-301
NCT01546571
April 2012
October 2018
Name | Location |
---|---|
University of Iowa Hospitals and Clinics | Iowa City, Iowa 52242 |
Washington University School of Medicine | Saint Louis, Missouri 63110 |
Mount Sinai School of Medicine | New York, New York 10029 |
University of Arkansas for Medical Sciences | Little Rock, Arkansas 72205 |
Central Baptist Hospital | Lexington, Kentucky 40503 |
City of Hope | Duarte, California 91010 |
Mount Sinai Medical Center | Miami Beach, Florida 33140 |
Research Across America | Carrollton, Texas 75010 |
University of Arizona Cancer Center | Tucson, Arizona 85724 |
Anschutz Cancer Pavilion | Aurora, Colorado |
The Angeles Clinic and Research Institute | Los Angeles, California 90025 |
Investigative Clinical Research of Indiana | Indianapolis, Indiana 46254 |
Wake Research Associates | Raleigh, North Carolina 27612 |
St. Louis Hospital | St. Louis, Missouri 63110 |
Intermountain Medical Center | Murray, Utah 84157 |
Dallas Surgical Group | Dallas, Texas 75235 |
Norris Cotton Cancer Center / Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire 03756 |
Clinical Research Associates of Tidewater | Norfolk, Virginia 23507 |
John Theurer Cancer Center | Hackensack, New Jersey 07601 |
MD Anderson Cancer Center-Orlando | Orlando, Florida 32806 |
Ameriderm Research | Jacksonville, Florida 32216 |
Northern California Melanoma Center/ St. Mary's Medical Center | San Francisco, California 94117 |
The Melanoma Center at the Washington Cancer Institute | Washington, District of Columbia 20010 |
Oncology Specialists, SC (OSSC) | Niles, Illinois 60714 |
Central Kentucky Research Associates | Lexington, Kentucky 40509 |
Center for Pharmaceutical Research | Kansas City, Missouri 64114 |
Wake Forest University School of Medicine, Comprehensive Cancer Center | Winston-Salem, North Carolina 27157 |
Kimmel Cancer Center at Thomas Jefferson Univ. | Philadelphia, Pennsylvania 19107 |
The Huntsman Cancer Institute, University of Utah | Salt Lake City, Utah 84112-5550 |
Arizona Clinical Research | Tucson, Arizona 85715 |
Pacific Dermatology Institute | Temecula, California 92592 |
University of Minnesota Masonic Cancer Institute | Minneapolis, Minnesota 55455 |
Mayo Clinic Cancer Center, Mayo Clinic Rochester | Rochester, Minnesota 55905 |
Cancer Center of NJ | New Brunswick, New Jersey 08901 |
University of Virginia Hospital | Charlottesville, Virginia 22908 |